Alpha,beta-dicarbonyl intermediates of advanced glycation end-product formation (RCS)

Alpha,beta-dicarbonyl intermediates, such as methylglyoxal (MGO), glyoxal, and 3-deoxyglucosone (3-DG), are highly reactive electrophilic metabolites that serve as the primary precursors for the formation of advanced glycation end-products (AGEs) (PMID: 24508246). These compounds are generated through the Maillard reaction, the polyol pathway, and glycolytic bypass, and they possess a significantly higher glycating potential than glucose itself (PMID: 21115333). Accumulation of these intermediates leads to a state known as dicarbonyl stress, which causes irreversible damage to proteins, DNA, and lipids, contributing to the structural and functional decline of tissues (PMID: 27184158). This process is a central driver in the development of diabetic complications, including nephropathy and retinopathy, as well as age-related conditions like Alzheimer's disease and atherosclerosis (PMID: 15180497). Therapeutic strategies target these intermediates using dicarbonyl scavengers—nucleophilic agents that chemically trap the dicarbonyls to prevent AGE cross-linking (PMID: 26433114). While compounds like aminoguanidine and pyridoxamine have demonstrated efficacy in preclinical models, clinical success has been limited by the need for high specificity to avoid interfering with essential physiological carbonyls like pyridoxal phosphate.

Other names

Reactive dicarbonyl speciesDicarbonyl compoundsAGE precursorsMethylglyoxalGlyoxal3-DeoxyglucosoneReactive carbonyl species

Chemical scavenging and nucleophilic trapping of reactive dicarbonyl species to inhibit the formation of advanced glycation end-products (AGEs).